Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) Study.

Emilie D, Burgard M, Lascoux-Combe C, Laughlin M, Krzysiek R, Pignon C, Rudent A, Molina JM, Livrozet JM, Souala F, Chene G, Grangeot-Keros L, Galanaud P, Sereni D, Rouzioux C; Primoferon A Study Group.

AIDS. 2001 Jul 27;15(11):1435-7.

PMID:
11504966
[PubMed - indexed for MEDLINE]
2.

Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.

Dominguez S, Ghosn J, Valantin MA, Schruniger A, Simon A, Bonnard P, Caumes E, Pialoux G, Benhamou Y, Thibault V, Katlama C.

AIDS. 2006 May 12;20(8):1157-61. Review.

PMID:
16691067
[PubMed - indexed for MEDLINE]
3.

Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus.

Aguilar Marucco D, Veronese L, de Requena DG, Bonora S, Calcagno A, Cavecchia I, Sinicco A, De Rosa FG, Cariti G, Di Perri G.

J Antimicrob Chemother. 2007 Mar;59(3):565-8. Epub 2007 Jan 9.

PMID:
17213263
[PubMed - indexed for MEDLINE]
Free Article
4.

Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.

Myers RP, Benhamou Y, Bochet M, Thibault V, Mehri D, Poynard T.

AIDS. 2004 Jan 2;18(1):75-9.

PMID:
15090832
[PubMed - indexed for MEDLINE]
5.

Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.

Schulze Zur Wiesch J, Pieper D, Stahmer I, Eiermann T, Buggisch P, Lohse A, Hauber J, van Lunzen J.

Clin Infect Dis. 2009 Aug 1;49(3):466-72. doi: 10.1086/600399.

PMID:
19580412
[PubMed - indexed for MEDLINE]
Free Article
6.

Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.

Reiberger T, Rasoul-Rockenschaub S, Rieger A, Ferenci P, Gangl A, Peck-Radosavljevic M.

Eur J Clin Invest. 2008 Jun;38(6):421-9. doi: 10.1111/j.1365-2362.2008.01958.x.

PMID:
18489402
[PubMed - indexed for MEDLINE]
7.

Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

Moreno L, Quereda C, Moreno A, Perez-Elías MJ, Antela A, Casado JL, Dronda F, Mateos ML, Bárcena R, Moreno S.

AIDS. 2004 Jan 2;18(1):67-73.

PMID:
15090831
[PubMed - indexed for MEDLINE]
8.

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection.

Torriani FJ, Ribeiro RM, Gilbert TL, Schrenk UM, Clauson M, Pacheco DM, Perelson AS.

J Infect Dis. 2003 Nov 15;188(10):1498-507. Epub 2003 Nov 13.

PMID:
14624375
[PubMed - indexed for MEDLINE]
Free Article
9.

Role of pegylated interferon-alpha-2a and ribavirin concentrations in sustained viral response in HCV/HIV-coinfected patients.

Lopez-Cortes LF, Valera-Bestard B, Gutierrez-Valencia A, Ruiz-Valderas R, Jimenez L, Arizcorreta A, Terrón A, Viciana P.

Clin Pharmacol Ther. 2008 Nov;84(5):573-80. doi: 10.1038/clpt.2008.110. Epub 2008 Jul 2.

PMID:
18596682
[PubMed - indexed for MEDLINE]
10.

Virologic and immunologic activity of PegIntron in HIV disease.

Angel JB, Greaves W, Long J, Ward D, Rodriguez AE, Scevola D, DeJesus E.

AIDS. 2009 Nov 27;23(18):2431-8. doi: 10.1097/QAD.0b013e32832f30ca.

PMID:
19898218
[PubMed - indexed for MEDLINE]
11.

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.

Crespo M, Mira JA, Pineda JA, Van den Eynde E, Ríos-Villegas MJ, Collado A, Girón-González JA, López-Cortés LF, González-Serrano M, Rivero A, Merino D, Esteban JI.

J Antimicrob Chemother. 2008 Oct;62(4):793-6. doi: 10.1093/jac/dkn262. Epub 2008 Jun 21.

PMID:
18567911
[PubMed - indexed for MEDLINE]
Free Article
12.

Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.

Opravil M, Sasadeusz J, Cooper DA, Rockstroh JK, Clumeck N, Clotet B, Montaner J, Torriani FJ, Depamphilis J, Dieterich DT.

J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):36-49.

PMID:
18156990
[PubMed - indexed for MEDLINE]
13.

Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.

Pineda JA, Mira JA, Gil Ide L, Valera-Bestard B, Rivero A, Merino D, Girón-González JA, Ríos-Villegas MJ, González-Serrano M, Collado A, García-García JA, Carrillo-Gómez R, López-Cortés LF, Gómez-Mateos J.

J Antimicrob Chemother. 2007 Dec;60(6):1347-54. Epub 2007 Oct 14.

PMID:
17938129
[PubMed - indexed for MEDLINE]
Free Article
14.

Open, randomized, multicentre italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART.

Cargnel A, Angeli E, Mainini A, Gubertini G, Giorgi R, Schiavini M, Duca P; Italian Co-infection Study (ICOS) Group.

Antivir Ther. 2005;10(2):309-17.

PMID:
15865225
[PubMed - indexed for MEDLINE]
15.

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.

Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.

AIDS. 2008 Aug 20;22(13):1583-8. doi: 10.1097/QAD.0b013e328305bd77.

PMID:
18670217
[PubMed - indexed for MEDLINE]
16.

Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response.

Fuster D, Planas R, Gonzalez J, Force L, Cervantes M, Vilaró J, Roget M, García I, Pedrol E, Tor J, Ballesteros AL, Salas A, Sirera G, Videla S, Clotet B, Tural C.

Antivir Ther. 2006;11(4):473-82. Erratum in: Antivir Ther. 2006;11(5):667.

PMID:
16856621
[PubMed - indexed for MEDLINE]
17.

Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.

Neumann A, Polis M, Rozenberg L, Jackson J, Reitano K, McLaughlin M, Koratich C, Dewar R, Masur H, Haagmans B, Kottilil S.

AIDS. 2007 Sep 12;21(14):1855-65.

PMID:
17721093
[PubMed - indexed for MEDLINE]
18.

Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

Berenguer J, González-García J, López-Aldeguer J, Von-Wichmann MA, Quereda C, Hernando A, Sanz J, Tural C, Ortega E, Mallolas J, Santos I, Miralles P, Montes ML, Bellón JM, Esteban H; GESIDA HIV/HCV cohort.

J Antimicrob Chemother. 2009 Jun;63(6):1256-63. doi: 10.1093/jac/dkp106. Epub 2009 Apr 10.

PMID:
19363085
[PubMed - indexed for MEDLINE]
Free Article
19.
20.

Pegylated interferon-alpha2a and ribavirin in HIV-hepatitis C coinfected patients.

[No authors listed]

Expert Rev Anti Infect Ther. 2004 Jun;2(3):341-2. No abstract available.

PMID:
15490503
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk